The genetics of angle closure glaucoma.


Journal

Experimental eye research
ISSN: 1096-0007
Titre abrégé: Exp Eye Res
Pays: England
ID NLM: 0370707

Informations de publication

Date de publication:
12 2019
Historique:
received: 30 06 2019
revised: 25 09 2019
accepted: 10 10 2019
pubmed: 22 10 2019
medline: 23 2 2020
entrez: 22 10 2019
Statut: ppublish

Résumé

Glaucoma, the leading cause of irreversible blindness worldwide, can be divided into two major types: primary open angle glaucoma (POAG) and primary angle closure glaucoma (PACG). PACG could lead to severe vision loss and has a high prevalence among Asian populations. The worldwide population affected by PACG is estimated to exceed 20 million by 2020. Recent studies have shown that there are at least eight genetic loci significantly associated with risk of PACG, possibly contributing to the phenotype by interacting with environmental factors. This review presents the progress that has been achieved in the genetics of PACG and its future perspectives. This article should be considered as a memorial article to honor Dr. R. Rand Allingham's remarkable contribution to genetic association studies in glaucoma. We are deeply saddened by the loss of Dr. Allingham, not only a huge loss for ophthalmology, but also loss of a dear friend. Looking back to his extraordinary career, Dr. Allingham devoted his whole life and passion into establishing the genetic basis of different forms of glaucoma such as open angle, angle closure, and exfoliation glaucoma. He had a special interest in analyses of populations from African ancestry, which greatly boosted the understanding of glaucoma genetics.

Identifiants

pubmed: 31634478
pii: S0014-4835(19)30476-2
doi: 10.1016/j.exer.2019.107835
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

107835

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Jin Wang (J)

Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Mayinuer Yusufu (M)

Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Key Laboratory of Ophthalmology and Visual Sciences, China.

Chiea Chuen Khor (CC)

Singapore Eye Research Institute, Singapore; Genome Institute of Singapore, Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Tin Aung (T)

Singapore Eye Research Institute, Singapore; Singapore National Eye Center, Singapore, Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Ningli Wang (N)

Beijing Tongren Hospital, Capital Medical University, Beijing, China; Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Key Laboratory of Ophthalmology and Visual Sciences, China. Electronic address: wningli@vip.163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH